- ►annals.org R Kunz, C Friedrich, M Wolbers, JFE Mann - Annals of Internal Medicine, 2007 - Am Coll Physicians This position paper concerns improving health care in the United States. Unlike
previous highly focused policy papers by the American College of Physicians,
this article takes a comprehensive approach to improving access, quality, ... Cited by 115 - Related articles - BL Direct - All 6 versions
K Tamura, J Yamauchi, Y Tsurumi-Ikeya, M … - Clinical and Experimental Hypertension, 2008 - informahealthcare.com The purpose of this study was to examine a possible difference in the 24-h blood
pressure (BP) profile between hypertensives with diabetic nephropathy (DN) and
those with non-diabetic glomerulopathy (non-DN). We measured 24-h ... Cited by 4 - Related articles - BL Direct - All 6 versions
A Takahara - Cardiovascular Therapeutics - interscience.wiley.com Cilnidipine is a unique Ca 2+ channel blocker with an inhibitory action on the
sympathetic N-type Ca 2+ channels, which is used for patients with hypertension
in Japan. Cilnidipine has been clarified to exert antisympathetic actions ... Cited by 1 - Related articles - All 2 versions
C Position, G Background - cigna.com Page 1 of 24 Coverage Position Number: 7005 ... Revised Date ..................
........... 9/15/2008 Original Effective Date ............. 9/15/2007 Next
Review Date……………….9/15/2009 Coverage Position Number ........... ... Related articles - View as HTML
АВ Добровольский, БКК … - wwwrmj.ru 1 Первый препарат этой группы – нифедипин –
был создан в 1966 году [1]. Первые результаты
клинического применения нифедипина были ... Related articles - Cached - All 15 versions
P Boutouyrie - Thérapie, 2009 - edpsciences. org Thérapie 2009 Juillet-Août; 64 (4): 241–248 DOI: 10.2515/therapie/2009047 c
2009 Société Française de Pharmacologie et de Thérapeutique ... Inhibiteurs
de l'enzyme de conversion et ... 1 Université Paris-Descartes, Faculté ... Related articles - All 2 versions
